腹膜透析患者糖尿病肾病组与非糖尿病肾病组对比
2016-08-02魏仲南
林 武 唐 娟 魏仲南 吴 强
腹膜透析患者糖尿病肾病组与非糖尿病肾病组对比
林 武 唐 娟 魏仲南 吴 强
【摘要】目的 探讨糖尿病肾病与非糖尿病肾病腹膜透析患者的一般情况的差别,从而指导临床治疗。方法 选取我院2013年3月~2015年4月收治的行腹膜透析的糖尿病肾病患者与非糖尿病肾病患者各60例为研究对象,对两组患者一般资料、临床检查指标、透析持续时间及并发症进行比较。结果 两组患者性别比例、血钙及透析后Hb等差异比较无统计学意义(P>0.05),糖尿病肾病组年龄为(67.35±13.48)岁,血磷为(2.51±0.73)mmol/L,与非糖尿病肾病组比较差异具有统计学意义(P<0.05);透析后ALB为(32.09±3.43)g/L,透析持续时间为(22.64±15.38)月,与非糖尿病肾病组比较差异具有统计学意义(P<0.05);透析期间腹膜炎发生率为60.00%,比非糖尿病肾病组高(P<0.05)。结论 糖尿病肾病患者与非糖尿病肾病患者相比,年龄普遍较大,透析持续时间短,透析后各项实验室指标及营养状况均较差,且患者并发症较多。分析表明糖尿病肾病患者预后较差与患者年龄大以及营养状况差有关。
【关键词】腹膜透析;糖尿病肾病;非糖尿病肾病
Objective To explore difference of general information of diabetic nephropathy and non-diabetic nephropathy peritoneal dialysis patients,so as to guide clinical treatment. Methods 60 diabetic nephropathy patients and 60 non-diabetic nephropathy patients who underwent peritoneal dialysis in our hospital from March 2013 to April 2015 were selected as study subjects,general information,clinical examination indexes,time of dialysis and complications in the two groups were compared. Results There was no significant difference in difference in sex ratio,blood calcium and Hb after dialysis between the two groups(P> 0.05),age of diabetic nephropathy group was(67.35±13.48)years old,serum phosphorus was(2.51±0.73)mmol/L,which were significantly higher than the non-diabetic nephropathy group(P<0.05),ALB after dialysis was(32.09±3.43)g/L,time of dialysis was(22.64±15.38)months,which were significantly lower than non-diabetic nephropathy group(P<0.05),incidence of peritonitis during dialysis was 60.00%,which was significantly higher than non-diabetic nephropathy group(P<0.05). Conclusion Compared with non-diabetic nephropathy patients,diabetic nephropathy patients are generally older,time of dialysis is short,various laboratory indexes after dialysis and nutritional status are poor with more complications. The analysis shows that poor prognosis of diabetic nephropathy patients relates to older age and poor nutritional status.
【Key words】 Peritoneal dialysis,Diabetic nephropathy,Non-diabetic nephropathy
糖尿病肾病是临床常见疾病,终末期患者一般会存在肾功能衰竭、心脑血管病变、视网膜病变以及感染和营养不良等多种并发症[1]。临床上对糖尿病肾病终末期患者一般采取腹膜透析疗法,它是利用自身腹膜作为透析膜,向腹腔内注入透析液,通过弥散、对流和超滤的原理,以清除体内过多的水分及代谢产物[2]。本次研究通过对我院收治的行腹膜透析的糖尿病肾病患者与非糖尿病肾病患者进行分析,来探讨两种患者的一般情况的差别,从而指导临床治疗,现总结报道如下。……
